v3.22.2.2
Acquisition (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 22, 2021
Jul. 31, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Aug. 12, 2022
Acquisition (Details) [Line Items]                  
Common shares issued (in Shares) 10,132,047                
Common shares outstanding (in Shares) 10,132,047   10,207,212   10,207,212   10,207,212    
Economic life             10 years    
Notes payable     $ 209,025   $ 209,025   $ 469,252   $ 468,137
Notes payable interest rate                 9.00%
Interest expense     $ 4,501 $ 10,586      
Weighted average cost of capital     37.50%   37.50%   33.80%    
Prepaid royalties     $ 339,091   $ 339,091   $ 339,091 $ 344,321  
Warrants to purschase common stock (in Shares)             749,984    
Stike price per share (in Dollars per share)             $ 20    
Warrants term     6 years 2 months 15 days   6 years 2 months 15 days   5 years    
Net sales percent             6.00%    
International net sales             $ 50,000,000    
Deferred revenue, period increase (decrease)             $ 200,000,000    
Cash payment percentage             10.00%    
Liquidation preference             $ 20,000,000    
Proceeds of net sale percentage             15.00%    
Purchase price consideration         $ 7,774,000        
Contingent consideration liability              
Stock exchange acquisition common stock (in Shares)     10,207,212   10,207,212   10,132,212 8,982,212  
Common stock, shares,outstanding (in Shares)     10,207,212   10,207,212   10,132,212 8,982,212  
Marizyme [Member]                  
Acquisition (Details) [Line Items]                  
Stock exchange acquisition common stock (in Shares) 10,132,212                
Common stock, shares,outstanding (in Shares) 10,132,212                
Royalties [Member]                  
Acquisition (Details) [Line Items]                  
Net sales percent             5.00%    
International net sales             $ 50,000,000    
Royalties [Member] | Minimum [Member]                  
Acquisition (Details) [Line Items]                  
Net sales percent             4.00%    
Royalties [Member] | Maximum [Member]                  
Acquisition (Details) [Line Items]                  
Net sales percent             2.00%    
Deferred revenue, period increase (decrease)             $ 50,000,000    
Net sales greater             $ 200,000,000    
Common Stock [Member]                  
Acquisition (Details) [Line Items]                  
Restricted shares issued (in Shares)             2,500,000    
Performance Warrants [Member]                  
Acquisition (Details) [Line Items]                  
Warrants to purschase common stock (in Shares)             1,000,000    
Pediatric Voucher Warrants [Member]                  
Acquisition (Details) [Line Items]                  
Warrants to purschase common stock (in Shares)             62,500    
Warrants term             5 years    
Trade Name [Member]                  
Acquisition (Details) [Line Items]                  
Economic life         14 years        
Software [Member]                  
Acquisition (Details) [Line Items]                  
Economic life         15 years        
Lab on Chip Technology [Member]                  
Acquisition (Details) [Line Items]                  
Economic life         17 years        
Somah Acquisition [Member]                  
Acquisition (Details) [Line Items]                  
Purchase price consideration   $ 9,926,000              
Somah Acquisition [Member] | Minimum [Member]                  
Acquisition (Details) [Line Items]                  
Contingent consideration liability             $ 1,387,000    
Somah Acquisition [Member] | Maximum [Member]                  
Acquisition (Details) [Line Items]                  
Contingent consideration liability   $ 11,313,000              
My Health Logic Inc. [Member]                  
Acquisition (Details) [Line Items]                  
Notes payable             $ 468,137    
Notes payable interest rate             9.00%    
Weighted average cost of capital               37.50%  
Purchase price consideration             $ 7,774,000    
Debt maturity date             Aug. 12, 2022    
Interest expense on notes payable             $ 1,115  
My Health Logic Inc. [Member] | Trade Name [Member]                  
Acquisition (Details) [Line Items]                  
Economic life             14 years    
My Health Logic Inc. [Member] | Lab On Chip Technology [Member]                  
Acquisition (Details) [Line Items]                  
Economic life             17 years    
My Health Logic Inc. [Member] | Software Development [Member]                  
Acquisition (Details) [Line Items]                  
Economic life             15 years    
Health Logic Interactive Inc. [Member]                  
Acquisition (Details) [Line Items]                  
Common shares issued (in Shares) 1,150,000                
Common shares held and administered (in Shares) 57,499                
Percentage of issued and outstanding 11.35%                
Unit Purchase Agreement [Member]                  
Acquisition (Details) [Line Items]                  
Notes payable     $ 278,678   $ 278,678        
DuraGraft [Member]                  
Acquisition (Details) [Line Items]                  
Economic life             13 years    
HL II Holding [Member]                  
Acquisition (Details) [Line Items]                  
Stock exchange acquisition common stock (in Shares) 1,150,000                
Common stock issued held and administered (in Shares) 57,499                
Total number of issued and outstanding percnet 11.35%